The estimated Net Worth of David P. Scharf is at least $3.25 millió dollars as of 24 July 2013. David Scharf owns over 65,382 units of Baxter International stock worth over $3,251,831 and over the last 15 years David sold BAX stock worth over $0.
David has made over 2 trades of the Baxter International stock since 2012, according to the Form 4 filled with the SEC. Most recently David exercised 65,382 units of BAX stock worth $3,468,515 on 24 July 2013.
The largest trade David's ever made was exercising 65,382 units of Baxter International stock on 24 July 2013 worth over $3,468,515. On average, David trades about 4,769 units every 25 days since 2010. As of 24 July 2013 David still owns at least 82,807 units of Baxter International stock.
You can see the complete history of David Scharf stock trades at the bottom of the page.
David's mailing address filed with the SEC is ONE BAXTER PARKWAY, , DEERFIELD, IL, 60015.
Over the last 22 years, insiders at Baxter International have traded over $966,809,165 worth of Baxter International stock and bought 178,227 units worth $6,261,495 . The most active insiders traders include Point Llc Loeb Daniel S Third, Michael F Mahoney és Jeffrey A Craig. On average, Baxter International executives and independent directors trade stock every 37 days with the average trade being worth of $3,609,738. The most recent stock trade was executed by Jeanne K Mason on 1 March 2024, trading 64,488 units of BAX stock currently worth $2,397,019.
baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
Baxter International executives and other stock owners filed with the SEC include: